Canada Insulin Delivery Devices Market Size & Outlook
Related Markets
Canada insulin delivery devices market highlights
- The Canada insulin delivery devices market generated a revenue of USD 1,506.7 million in 2025 and is expected to reach USD 2,690.9 million by 2033.
- The Canada market is expected to grow at a CAGR of 7.5% from 2026 to 2033.
- In terms of segment, insulin pens was the largest revenue generating product in 2025.
- Insulin Pumps is the most lucrative product segment registering the fastest growth during the forecast period.
Insulin delivery devices market data book summary
| Market revenue in 2025 | USD 1,506.7 million |
| Market revenue in 2033 | USD 2,690.9 million |
| Growth rate | 7.5% (CAGR from 2026 to 2033) |
| Largest segment | Insulin pens |
| Fastest growing segment | Insulin Pumps |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Insulin Pens, Insulin Pumps, Insulin Pen Needles, Insulin Syringes |
| Key market players worldwide | Novo Nordisk A/S ADR, Sanofi SA, Eli Lilly and Co, Ypsomed Holding AG, Medtronic PLC, Abbott Laboratories, Roche, Biocon, Wockhardt |
Other key industry trends
- In terms of revenue, Canada accounted for 7.8% of the global insulin delivery devices market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In North America, U.S. insulin delivery devices market is projected to lead the regional market in terms of revenue in 2033.
- Mexico is the fastest growing regional market in North America and is projected to reach USD 796.8 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Insulin Delivery Devices Market Scope
Insulin Delivery Devices Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Wockhardt | View profile | 10001+ | Mumbai, Maharashtra, India, Asia | http://wockhardt.com |
| Biocon | View profile | 10001+ | Bangalore, Karnataka, India, Asia | http://www.biocon.com |
| Ypsomed Holding AG | View profile | 2400 | Brunnmattstrasse 6, Burgdorf, Switzerland, 3401 | https://www.ypsomed.com |
| Roche | View profile | 10001+ | Basel, Basel-Stadt, Switzerland, Europe | http://www.roche.com |
| Novo Nordisk A/S ADR | View profile | 66015 | Novo Alle 1, Bagsvaerd, Denmark, 2880 | https://www.novonordisk.com |
| Eli Lilly and Co | View profile | 43000 | Lilly Corporate Center, Indianapolis, IN, United States, 46285 | https://www.lilly.com |
| Sanofi SA | View profile | 87994 | 46, avenue de la Grande Armée, Paris, France, 75017 | https://www.sanofi.com |
| Medtronic PLC | View profile | 95000 | Lower Hatch Street, 20 On Hatch, Dublin, Ireland, 2 | https://www.medtronic.com |
| Abbott Laboratories | View profile | 114000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | https://www.abbottinvestor.com |
Canada insulin delivery devices market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to insulin delivery devices market will help companies and investors design strategic landscapes.
Insulin pens was the largest segment with a revenue share of 47.12% in 2025. Horizon Databook has segmented the Canada insulin delivery devices market based on insulin pens, insulin pumps, insulin pen needles, insulin syringes covering the revenue growth of each sub-segment from 2021 to 2033.
According to the Canadian Diabetes Association, around 30% of Canadians are currently living with diabetes or prediabetes, with only 10% having been diagnosed so far, and the figure increased to 14% when cases of undiagnosed type 2 diabetes were included.
This can result in a shorter lifespan of up to 15 years due to complications associated with the disease, and the all-cause mortality rate among Canadians with diabetes is twice as high as those without it.
However, treatment adherence is often affected by cost, as most Canadians with diabetes pay over USD 1,500 per year or over 3% of their income for prescribed medications, devices, and supplies out-of-pocket.
Reasons to subscribe to Canada insulin delivery devices market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Canada insulin delivery devices market databook
-
Our clientele includes a mix of insulin delivery devices market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada insulin delivery devices market , including forecasts for subscribers. This country databook contains high-level insights into Canada insulin delivery devices market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
Canada Product - Insulin Delivery Devices Market size, 2025 - 2033 (US$M)
Canada Insulin Delivery Devices Market Outlook Share, 2025 & 2033 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
